Olle Bergman International Writing and Scientific Communications Expert
Bergmans Bokstäver AB
Olle Bergman is a writer, consultant and communications trainer, serving professionals in the fields of science, medicine and tech. Starting out in wet lab research, he soon chose to follow a communications career. Today he is a freelancing “pen for hire” and advisor based in Sweden, doing international assignments for different media as well as for organizations like The Swedish Cancer Society and Scania. On a daily basis, he is interacting and networking with a large number of people and organizations in academia, industry and the startup world. In addition, he is helping early career scientists to develop their communication skills.
Dee Bojanic, PhD, CMPP is the Head of Global Scientific Publications at Gilead Sciences. In her role, Dee is leading efforts to transform publications group into a trusted global publications leader that is broadly recognized for planning and developing impactful scientific publications with the highest integrity that will benefit patient care. In addition, she has established Gilead’s first publication policy and is working on optimizing and implementing the systems for publication development and tracking. Dee has over 10 years of experience in scientific and medical communications with the focus on publication planning and development. Dee received her PhD in Biological Chemistry and her undergraduate degree in psychobiology at University of California, Los Angeles.
Head of Client Partnerships & Managing Director, EMEA
Andy Bowman Head of Client Partnerships & Managing Director, EMEA
Andy is a healthcare communications specialist with over 30 years of experience within the global pharmaceutical and biotechnology sectors and has the responsibility of leading the partnership efforts for Within3 worldwide.
Andy started his pharmaceutical career as a medical representative in the UK with Glaxo, progressing within the industry through training, sales management and marketing before leaving the client side of the business to take up senior roles in advertising, PR, sales promotion, direct marketing, clinical research, medical education and publications.
Andy is an accredited member of the British Psychological Society (BPS) and certified in Rational Emotive Behavioral Therapy and Counselling. He is a Certified Medical Publications Professional (CMPP) and a Practitioner at the Association for Business Psychology.
Ana Bozas, PhD, CMPP Associate Director Global Medical Communications
Akcea Therapeutics, Inc.
Ana is the Associate Director of Global Medical Communications at Akcea Therapeutics, a leader in rare disease therapies. Ana has a PhD in Biochemistry from the University of Utah and began her career as a research associate and medical writer before managing publications for therapeutics organizations. During her time in the industry, Ana has led publication strategy from department inception to near-patent-expiry post-marketing, across the globe (including Emerging Markets). Over her medical communications & research career, she has produced 50+ publications. Ana is passionate about career development and peer mentoring and has been active in the local (Greater Boston Area, MA) career mentoring scene.
Iwona Bucior is a Senior Director at Bristol Myers Squibb, responsible for the vision and direction for Medical Strategy, Medical Education, Medical Communication and Publications. She holds a PhD in Biochemistry from the University of Basel in Switzerland, followed by a postdoctoral and specialty fellowships at UCSF, Department of Medicine.
Iwona has over 25 years of combined experience in Medical Affairs and Medical Communications. As the Medical Strategy Lead, Iwona prepared and oversaw Medical Launch plans and Medical Education initiatives, with Publications being a key and integrated educational strategy.
Iwona built Medical Communications and Publications groups, created multidisciplinary resources and platforms, implemented policies and best practices in compliance with Good Publication Practice and global transparency regulations. She developed research-based communication platforms and publication planning for early phases, product launch, and post-launch across a broad range of therapy areas. Furthermore, she led projects focused on Real-World Evidence and Health Economic and Outcomes Research to build and communicate clinical and economic evidence to regulators, providers, healthcare decision-makers, and payers.
Beth received her undergraduate degree from Texas A&M University in Communication and Health. She then went to the University of Alabama, Birmingham to obtain her Masters in Public Health. As a part of her Masters program, she spent over 2 years in Guatemala as a Peace Corps Volunteer. Following her Masters, she went on to pursue a PhD in Nutritional Epidemiology from the University of California, Davis. Upon completion of her PhD, she went to work as an epidemiologist at the Centers for Disease Control and Prevention. There she worked on women’s health, mother to child HIV transmission, obesity and fruit and vegetable consumption. She left her career in Public Health to come to W.L. Gore & Associates to work in research of medical devices. Beth has been at W.L. Gore & Associates for 11 years. In her role as CSL, she has worked with data from both thoracic and abdominal endovascular devices from a range of clinical trails from EFS to IDE.
Clinical Professor of Psychiatry and Behavioral Sciences, Editor Emeritus
New York Medical College, International Journal of Clinical Practice
Leslie Citrome Clinical Professor of Psychiatry and Behavioral Sciences, Editor Emeritus
New York Medical College, International Journal of Clinical Practice
Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation. Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author or co-author of over 500 research reports, reviews, and book chapters in the scientific literature, is on the editorial board of 11 different medical journals, Editor Emeritus at the International Journal of Clinical Practice and where he served as Editor in Chief from 2013 through 2019, reviews for over 75 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.
Lauren Deluca is the Executive Director and Founding President of CIAAG. She graduated from Nichols College with a Bachelor's Degree in Finance. She earned several professional designations including, Charter Property Casualty Underwriter with a concentration on Commercial Insurance, an Associates in Personal Insurance and Associate in General Insurance. She spent her career working as a Commercial Insurance Account Executive & Risk Manager specializing in Large & Middle Market accounts.
After a life altering medical emergency she Founded Chronic Illness Advocacy & Awareness Group to raise awareness of the impact healthcare policy changes are having on individuals with chronic illnesses, disease and conditions.
Lisa DeTora Associate Professor and Director of STEM Writing
Lisa DeTora is an Associate Professor and the Director of STEM Writing at Hofstra University where she teaches in various departments and programs including writing studies, rhetoric, disability studies, chemistry, biology, sports science, and narrative medicine. A long-time member of ISMPP’s Ethics and Standards committee, Lisa has co-authored several papers on topics in publication ethics, including authorship, ghostwriting, and everyday tactics for publications management. She has been a speaker at various TIPPA meetings since 2010, covering ethics beyond the ICMJE, authorship, plain language, and translating regulatory materials into publications. Lisa serves as the editor of Regulatory Writing: An Overview, a publication of the Regulatory Affairs Professional Society, which provides guidance and advice for writers of regulatory documentation in CMC, nonclinical, and clinical areas. Her scholarly work also includes studies in embodiment, graphic narrative, technical communication, and the rhetoric of health and medicine.
Director, Scientific Communications, Medical Affairs
Otsuka Pharmaceutical Development & Commercialization, Inc.
Faith DiBiasi Director, Scientific Communications, Medical Affairs
Otsuka Pharmaceutical Development & Commercialization, Inc.
Faith has more than 20 years of experience in the biotech and pharmaceutical industry, including 8 years at Roche leading the PCR technical support operations group and providing technical direction for strategic marketing. She spent 2 years at QIAGEN as Director of Global Marketing, and 7 years heading infectious disease & immunology publications and overseeing knowledge management at Human Genome Sciences Inc. Over the past 8 years she has been the Director of Scientific Communications in the Medical Affairs department at Otsuka Pharmaceutical Development & Commercialization, Inc. leading the publication efforts for CNS, Digital Medicine and most recently Oncology.
Before going to industry, Faith was a clinical microbiologist, an infectious disease researcher, and she taught Biology, Microbiology, and Bacterial Genetics at the University of Pittsburgh.
Faith has a BS in Microbiology and a paralegal certificate both from Penn State University, she is a board-certified Microbiologist, has an MBA in Marketing, and is an ISMPP CMPP™. In the past she has chaired the ISMPP abstract committee and the credentialing committee. She is currently on the Credentialing Board.
Director, Scientific Communications, Migraine and Headache, Global Medical Affairs
Sissy Easo-Joseph Director, Scientific Communications, Migraine and Headache, Global Medical Affairs
Sissy Easo-Joseph is a communications professional with 20 years of experience in the medical and scientific communications industry. Sissy is Director of Scientific Communications - Migraine and Headache, Global Medical Affairs, for Teva Pharmaceuticals, where she demonstrates collaborative leadership to foster awareness and accountability of good publication and scientific communications planning practices; develops very high quality, innovative and creative scientific communications, as well as, educational resources; ensures that all stakeholders have a comprehensive understanding of strategic planning and how it fits into overall communications plan. Her expertise affords opportunities to leverage the understanding of the therapeutic area and strategic communication principles, to create compelling communication plans. Moreover, her responsibilities includes advocacy development, financial and program management, operational experience in the execution of disease-state and product-related scientific communications, publications and educational initiatives, which support the strength of a communications, plan. She has an undergraduate degree in biology, a Master’s degree in Toxicology and a PhD in Health Administration.
Senior Director Publications & Scientific Communications
Lynne Gordon Senior Director, Scientific Publications and Medical Affairs
Lynne has worked in the pharmaceutical industry for over 25 years, in both large pharma and start-up biotech companies. She was a field-based Medical Science Liaison (MSL) for 15 years and has been in-house at Theravance Biopharma US, Inc. since 2011. In her current role, she is the sole publication professional and manages all things relating to publications for the five compounds in various stages of development, from Phase 1 to a commercialized product. Her other responsibilities include Medical Affairs operations such as departmental policies, guidelines and work instructions.
Dr. Grifman is an accomplished leader with almost 20 years of diverse biotech and pharmaceutical experience in R&D and Medical Affairs. Prior to her current role as Executive Director of Medical Affairs at Samumed, LLC, she was Director of Medical Affairs at GSK Vaccines and Teva Pharmaceuticals where she led Medical Science Liaison teams. Prior to her Medical Affairs roles, Dr. Grifman served in Business Development positions for the Government of Canada and Immusol. She started her career as a research scientist.
Dr. Grifman received her PhD in Biochemistry, MSc in Microbiology, and BSc in Biology at the Hebrew University of Jerusalem. She also was a postdoctoral fellow at the Salk Institute for Biological Studies.
Andrea Gwosdow PhD, Scientist, Medical and Science Writer
PhD, Scientist, Medical and Science Writer
Andrea Gwosdow is an award-winning medical and science writer and physiologist. She is President of Gwosdow Associates Science Consultants LLC, a science and medical communications firm that provides medical and science writing services and training, works with schools on science education, interprets science for non-scientists, and provides professional development for fellow writers. Andrea’s expertise is in scientific publications and she is known for clear explanations of complex scientific principles to a variety of audiences at all levels. She is an active member and Fellow of the American Medical Writers Association and has received the top awards from the New England Chapter of the American Medical Writers Association. She was awarded 2nd place in the 2014 R & D Pharmaceutical Awards for Clinical Writing. Dr. Gwosdow has worked around the world with a variety of organizations to improve their communication and writing skills through hands-on workshops, seminars, and presentations. These workshops led to the publication of her book, The Complete Guide to Scientific Manuscript Writing. Her academic appointments include Harvard Medical School and Yale University.
Caroline is the Digital Publishing Manager for Springer Healthcare (part of Springer Nature), based in Chester in the north west of England. Caroline represents the Adis portfolio of journals, including Advances in Therapy, Infectious Diseases and Therapy, CNS Drugs and Drug Safety. Since joining Springer in 2007 as an editor for Advances in Therapy, in recent years she has been involved in the launch and success of the Adis Rapid+ open access journals, and the roll out of new digital features designed to extend the reach of journal content, such as video abstracts, audioslides, animations, podcasts, and plain language summaries (PLS). Caroline started her career in medical communications at GCC (now part of Ashfield Healthcare Communications) in 1999, followed by a move to Prime Medica (now Prime Global) where she providing editorial support for their key publication planning accounts.
Laura E. Happe
Director, Online MS in Pharmaceutical Outcomes and Policy, University of Florida Clinical Associate Professor,
Laura E. Happe Director, Online MS in Pharmaceutical Outcomes and Policy, University of Florida Clinical Associate Professor,
University of Florida
Laura E. Happe, PharmD, MPH is an editor, professor and author who specializes in using data to aid in decision making. Laura leads an online Master’s degree program with approximately 150 students and 50 graduates annually at the University of Florida, School of Pharmacy, Department of Pharmaceutical Outcomes & Policy. Laura is also the Editor-in-Chief of the Journal of Managed Care and Specialty Pharmacy (JMCP), the official peer-reviewed journal of the Academy of Managed Care Pharmacy with a circulation of over 30,000 people. Previously, Laura was the Chief Pharmacy Officer of Humana, where she was responsible for advancing the clinical pharmacy acumen and integrating pharmacy into the company’s integrated care delivery model. During her time at Humana, she also enhanced the company’s research program, contributing to more than 70 peer-reviewed published manuscripts. Laura earned her Doctorate of Pharmacy degree from Creighton University and is a licensed pharmacist in both Florida and Arizona. She also holds a Master’s of Public Health degree with an emphasis in epidemiology from the University of South Florida and is fellowship trained in pharmacoeconomics and outcomes research. Laura’s first book, If You Give an Ox an Oxy, is an educational resource for parents to teach their adolescents about the hazards of opioid use.
Emmanuelle Hugentobler, MD Vice President, Medical Affairs
Emmanuelle Hugentobler joined the industry after obtaining her MD and specializing in cardiovascular diseases; from large pharma to start-up biotechnology companies, Emmanuelle has been working in positions of increasing responsibilities and has helped build teams both in the US and globally. With a passion for helping to bring medical innovation to patients, she is currently Vice President of Medical Affairs at Kiniksa Pharmaceuticals.
PharmD, Strategic Publications & Medical Education
Jessica Kirwan Managing Editor of International Journal of Particle Therapy
University of Florida Department of Radiation Oncology
Jessica Kirwan, MA, is Managing Editor of the International Journal of Particle Therapy, an open access peer-reviewed oncology journal she helped found in 2013. Jessica is passionate about building the readership and extending the reach of the journal, engaging the editorial board, and elevating the journal's impact. She has over 15 years' experience in medical publishing and serves as the Assistant Director of Research for the Department of Radiation Oncology at the University of Florida where she has coordinated and co-authored more than 50 radiation therapy outcomes studies. As a contributing writer to the online health humanities journal Synapsis and the Palgrave Encyclopedia of Victorian Women's Writing, Jessica's scholarly work examines the intersection of women's writing, women's health, and medicine in the nineteenth century. Jessica received her masters in English from the University of Florida where she is currently pursuing her doctorate.
Kelly Malloy VP Product Strategy, Publication Planning
Kelly brings 15 years of experience in the Life Sciences and Healthcare sectors, primarily supporting marketing, medical affairs and publication planning functions within pharmaceutical, medical device, and biotechnology organizations. Kelly holds a Bachelor of Science in Business Economics from the Smeal College of Business at Penn State University and has completed several master-level courses in Marketing & Management.
Leslie Moody, PhD, CMPP Senior Scientific Director
Cello Health Communications
Leslie Moody is Senior Scientific Director for Cello Health Communications. She has worked in medical communications for 14 years, supporting the communications needs of various products from early clinical development throughout the drug lifecycle and thoroughly enjoys the challenge of helping clients develop their scientific story and effectively communicating it. She holds a PhD in Immunology from the University of Texas Southwestern Medical Center at Dallas.
As a medical communications scientist, I have worked with various companies including Vertex, EMD Serono, Tesaro, and medDay Pharmaceuticals before joining Alexion over a year ago. Before taking the leap to the industry, I worked as an academic research scientist for over 10 years. I have a PhD in Pharmacology from the University of Toulouse, France.
Genevieve Nesom Publishing Ethics and Integrity Manager
Taylor & Francis
Genevieve Nesom is a Research Ethics and Integrity Manager at Taylor & Francis Group Publishers. She’s joined the now 5-person team in 2019 and couldn’t be happier with the fit. Prior to working at T&F, she worked in clinical research at the University of Pennsylvania (UPenn) and, more recently, the Children’s Hospital of Philadelphia (CHOP). While at CHOP she managed rare metabolic disease clinical trials, mostly funded by industry sponsors. During that time she also completed a dual degree master’s program at UPenn in public health and biomedical ethics. Her bachelors degree is in religious studies, which, altogether, seems to be a prudent preparatory exposure for working with content across T&F’s 2,000 diverse journals.
Director Medical Communications and Medical Information
Shweta Rane Director, Global Scientific Communications
Alexion Pharmaceuticals, Inc.
Shweta Rane, PhD, ISMPP CMPPTM is the Director of Global Scientific Communications at Alexion Pharmaceuticals, with over 16 years of combined experience (academia and industry) in R&D and medical affairs. She started in R&D as a Senior Scientist at GlaxoSmithKline (GSK) and then transitioned to medical/scientific communications. Prior to joining Alexion Pharmaceuticals, she held positions with increasing responsibilities at Takeda Pharmaceuticals, Mallinckrodt Pharmaceuticals, and GSK. She is a seasoned medical/scientific communications professional working on pre- and post-launch products from both regional and global perspectives, including working under a corporate integrity agreement.
Dr. Rane has an extensive experience across multiple therapeutic areas including cardiovascular diseases, gastroenterology, hematology, immunology, neurogastroenterology, neurology, post-transplant medications, psychiatry, and respiratory disorders. Recently, she has been leading medical & scientific communications strategies in orphan/rare and ultra-rare disease portfolios. Dr. Rane is an active member of ISMPP (with CMPP certification) serving on the CMPP Recertification and CMPP exam writing committees. She is also a member of Healthcare Businesswomen’s Association (HBA) and is currently the Director at Large – Programming for the HBA-Boston Chapter.
Dr. Rane received her Bachelor of Engineering (Biomedical) degree from Mumbai University, her MS in Cell and Molecular Biology from Long Island University, and her PhD in Cell and Molecular Medicine from the University of Medicine and Dentistry of New Jersey (now Rutgers New Jersey Medical School). She has also earned a mini-MBA from Rutgers University.
Shasta Rayne Harner is the Vice President of Chronic Illness Advocacy and Awareness Group, a patient rights organization that works to promote inclusion of disabled rights and individualized patient-centered care.
She graduated from Sonoma State University with a B.A. in Political Science. She worked for many years as a Certified Medical Assistant and Project Coordinator for a large medical group. In her career, she focused on the delivery of patient care to medical practice administration. Shasta lives with a rare, disabling autoimmune disease called dermatomyositis.
After the onset of her disease, Shasta gained insight into the experience of being a chronically ill patient in today’s medical/political climate. As a result of this experience combined with her work history, personal interests, disability and educational background, she was inspired to advocate for others who also have disabling conditions.
Samantha Rose Senior Manager, Global Medical Communications
Samantha Rose is a Senior Manager of Global Medical Communications at Allergan in Madison, New Jersey. In her current role, she leads publication planning, strategy and execution for the portfolio of retina-related products. Previous roles include management of locally-developed publications at Bristol-Myers Squibb and client services program management at ApotheCom, a medical communications agency. She is an ISMPP-certified medical publication professional (CMPP) and an active member of ISMPP currently serving on the CMPP Recertification Committee. She has a bachelor of science from The College of New Jersey and is currently pursuing an MBA at Fairleigh Dickinson University.
Burnedette Rose Hill
Deputy Director, Scientific & Medical Publications
Burnedette Rose Hill Deputy Director, Scientific & Medical Publications
Burnedette Rose Hill is a global strategic scientific and medical communications business partner, recognized for her outstanding ability to build and maintain valued stakeholder relations. Her key areas of expertise are scientific communications, key thought leader engagement, medical education and healthcare compliance.
Burnedette shines in her extraordinary leadership ability to influence and quickly build rapport and trust. She genuinely values different perspectives and opinions and is comfortable working through ambiguity. Burnedette takes a positive approach to handling difficult situations, while ensuring effective resolution.
Burnedette holds undergraduate degrees in Biology and Psychology and an MBA in International Business/Management. She successfully completed the Healthcare Compliance Certification Program at Seton Hall University School of Law and is well versed in PhRMA/IFPMA/AdvaMed Code, ICMJE, Good Publication Practices, Global transparency regulations, OIG, Foreign Corrupt Practice Act, Anti-Kickback Statue, False Claims Act, Sunshine Act and ACCME guidelines.
Burnedette has lived and worked in Europe and worked extensively throughout Europe, Asia, Middle-East and Latin America. She understands the global life science landscape and its demands for interacting in a compliant manner with patients, healthcare professionals and regulatory authorities.
Birgit Roy is the Senior Director and Head of Advocacy at MyoKardia. In this role, Birgit engages professional medical associations/societies, and patient advocates to understand needs that clinicians and patients have, and support education, awareness and advocacy. Prior to joining MyoKardia, Birgit has worked in academic and pharmaceutical research, as well as in industry and for a medical professional association (American College of Cardiology) in a variety of roles, including in Patient Advocacy and Professional Relations. Birgit has worked in the cardiovascular space for over 20 years. Birgit has a Bachelor of Science in Chemistry from the University of Michigan, Ann Arbor. She lived and worked in India for 6 years.
Head of Strategic Publications & Medical Education
Chirag Shah Head of Strategic Publications & Medical Education
Chirag Shah is a results-driven Medical Affairs Professional, Pharmacist, Speaker, Advisor, and Leader with vast experiences across clinical, academic, and industrial environments. His areas of expertise include medical affairs strategy and communications, publication planning and strategy, scientific exchange, medical education and training, and project management.
Chirag holds a leadership position as the Head of Strategic Publications and Medical Education at Neurocrine Biosciences. Chirag has experience working in a global team environment, managing large budgets across external business partners, and is very comfortable in a fast-paced, changing environment. His broad areas of expertise include immunology, central nervous system, inflammation, and medicine. Chirag obtained his Doctorate in Pharmacy from the Philadelphia College of Pharmacy. He speaks English, Gujarati, and Spanish.
A physician by training, Dr. Charlotte Singh is a Senior Publications Manager at Novo Nordisk Inc overseeing the US publications for digital health, insulins, obesity, and NASH. With almost 20 years’ experience in medical education on the agency side, Dr. Singh has extensive expertise in the development and execution of various medical communication plans. Her work includes several projects such as the development of strategic publication plans and execution of their tactics, healthcare provider and patient/caregiver medical education programs, and CME. She has also been instrumental in the launch of several products in global and domestic markets. Her roles have spanned scientific and client services, content development, and new business development. Her considerable knowledge in a wide variety of therapeutic areas and her background as a physician lend insights into the prescriber mindset. Dr. Singh earned her Bachelor of Science in Anthropology and Biochemistry, cum laude, from the State University of New York at Stony Brook and her Doctorate of Medicine, cum laude, from the State University of New York, Health Science Center at Brooklyn, College of Medicine.
John Smith Director, Scientific Communications, Solid Tumor Oncology
During his 20+ years in the pharmaceutical industry, John A Smith has led the U.S. strategic publication plan for an emerging blockbuster diabetes therapy, been lead medical writer on multiple high-impact publications, contributed to various regulatory documents leading to approval, and participated in the design and risk mitigation of a major outcome study. In his role as Director, Scientific Communications (Solid Tumor Oncology) at Janssen, John is now leading the development of U.S. publications, proactive and reactive MSL materials for launches, new indications, and conference summaries as well as education strategy.
For this roundtable at TIPPA, John will share his experiences in developing publication plans as well as being a user of publications as source documents from a range of materials. Given that “pubs are the hub” for a variety of materials (Medical Information letters, MSL materials, training, education, etc.) the goal of this roundtable is share experiences and challenges of being the gatekeeper of publications and managing requests for these confidential materials from a broad range of stakeholders.
John has presented on various topics related to publication planning, medical writing, and optimizing the pharma-med comm partnership for ISMPP, AMWA, Q1, and TIPPA. Before joining industry, John worked with the 1996 Australian Olympic team in Atlanta and taught health and exercise science courses at various U.S colleges for 4 years; experiences that prepared him to excel in industry.
Kelly Soldavin is a Medical Editor for the publisher Taylor & Francis Group and a member of their London-based Medicine & Health Editorial team. In this role, Kelly manages Current Medical Research & Opinion, a MEDLINE-indexed, peer-reviewed, international journal for the publication of original research focused on new and existing drugs, Phase II through IV studies, and post-marketing investigations. She previously managed Journal of Medical Economics and Journal of Drug Assessment. Kelly is an advocate for, and has a special interest in, open science and ethical and transparent publishing, as well as patient engagement and plain language summaries. She has spoken on these topics for the International Publication Planning Meeting (TIPPA), International Society for Medical Publication Professionals (ISMPP), and Special Libraries Association (SLA). In addition, Kelly is a member of the ISMPP Social Media & Web-based Metrics Working Group. Prior to joining T&F, Kelly spent 14 years in the veterinary medicine publishing industry. She works in Philadelphia and received her Bachelor of Science degree from Delaware Valley University, Doylestown, Pennsylvania.
Sudha Vemuri, PhD is a scientific communications expert with over 15 years of experience in development and execution of strategic publications and medical content in multiple therapeutic areas including oncology, immunology, cardiovascular and diabetes. Prior to her current role at Janssen as Director, Scientific Communications, Sudha had worked within Publications as well as Medical Information departments at Sanofi, Bristol-Myers Squibb, and Bayer. Sudha’s experience includes marketed products as well as pre-marketed products in various phases of development. She also has in-depth knowledge and expertise in developing field medical materials and other scientific content that is consistent with regulatory guidance. Sudha has been acknowledged for her strong leadership and development of direct reports as well as for partnering and driving strategy across cross-functional matrix teams, global teams, and alliance partners.
Mark has two decades of medical communications experience in academic, nonprofit, and corporate settings. He is currently manager of medical communications at MyoKardia, where he leads publications for the company's phase 3 drug candidate and pipeline drugs, working with internal and external stakeholders as well as medical communications agency partners. Previous to MyoKardia, Mark had his own consultancy where he worked with industry, individual investigators, medical centers, and nonprofit medical associations to create a variety of scientific publications, including online training material for HCPs, white papers, presentations, as well as the usual manuscripts, posters, and abstracts. While he works in the cardiology space now, much of his previous experience focused on infectious diseases, particularly HIV, with more than 10 years of research and writing in those areas.
Jamie L Weiss
Head of Global Publications, Global Medical Affairs
Jamie L Weiss Head of Global Publications, Global Medical Affairs
Jamie is the Head of Global Publications at LEO Pharma, was most recently Associate Director, Publications at Novartis and before that a Senior Medical Writer at Allergan. She has worked in the pharmaceutical industry for 10 years. Jamie was formally a professor of biomedical science/ principal investigator for 11 years. She has been writing in the biomedical science field for 21 years, and has a BA from Rutgers University and a PhD from Iowa State University, both in cellular biology. Public understanding of science and tailored digital innovation are some of Jamie’s passions.